English Українська
  • Main
  • Useful links
  • Information for Contributors
  • About
  • Editorial board

  • Article
    D. S. Avetikov, M. M. Ananieva, G. A. Loban, M. O. Faustova, M. G. Skikevych, Yu. V. Chumak, O. S. Ivanytska

    THE PROFILE OF SPECIFIC ANTIBODIES TO SARS-COV-2 IN RESIDENTS OF THE CENTRAL AND EASTERN REGIONS OF UKRAINE


    About the author: D. S. Avetikov, M. M. Ananieva, G. A. Loban, M. O. Faustova, M. G. Skikevych, Yu. V. Chumak, O. S. Ivanytska
    Heading CLINICAL MEDICINE
    Type of article Scentific article
    Annotation Determination of the level of antibodies in individuals living in certain regions provides insight into the epidemiology of the infection and is crucial for the development of strategies to reduce the spread of COVID-19. The study analyzed the results of IgM and IgG tests for the SARS-CoV-2 virus in 7142 residents of eastern and central regions of Ukraine from July 2020 to January 2021. Patients' visits to COVID-19 for IgM and IgG mainly occurred in the autumn-winter period of 2020–2021, confirming the seasonality of the disease. The most popular test among residents of Poltava and Donetsk regions was the test for IgM immunoglobulins, and the vast majority of results were negative. As of January 2021, the number of people who had IgG antibodies to the pathogen COVID-19, among those surveyed approached 50 % in both Poltava and Donetsk regions.
    Tags COVID-19, SARS-CoV-2, antibodies, IgM, IgG
    Bibliography
    • Zinchuk OM, Petrukh AV, Grynchyshyn NI, Shvaievs’ka KK. Osoblyvosti gumoralnoyi imunnoyi vidpovidi pry koronavirusniy khvorobi (COVID-19). Aktualna infektolohiya. 2021; 9(1): 33–36. doi: https://doi.org/10.22141/2312-413X.9.1.2021.228825. [in Ukrainian]
    • Kyseliova GL, Voronova KV, Isaiev VM. Diagnostychna znachymist vyiavlennia neitralizuyuchykh antytil do SARS-CoV-2. Aktualna infektolohiya. 2021; .9(1):24–27. doi: https://doi.org/10.22141/2312-413X.9.1.2021.228823. [in Ukrainian]
    • Koronavirus v Ukrayine. [Internet]. Minfin. 2022 [cited 2022 Jan 10]. Available from: https://index.minfin.com.ua/reference/coronavirus/ ukraine/ [in Russian]
    • Bhuiyan MU, Stiboy E, Hassan MZ, Chan M, Islam S, Haider N et al. Epidemiology of COVID-19 infection in young children under five years: A systematic review and meta-analysis. Vaccine. 2021; 39.4: 667. doi: 10.1016/j.vaccine.2020.11.078.
    • Byun WS, Heo SW, Jo G, Kim JW, Kim S, Lee S, et al. Is coronavirus disease (COVID-19) seasonal? A critical analysis of empirical and epidemiological studies at global and local scales. Environmental Research. 2021; 196: 110972. doi: 10.1016/j.envres.2021.110972.
    • Centers for Disease Control and Prevention. Interim Guidelines for COVID-19 antibody testing in clinical and public health settings. 2022. Available from: https://www.cdc.gov/coronavirus/2019-ncov/lab/resources/antibody-tests-guidelines.html
    • COVID-19 coronavirus pandemic. [Internet]. Worldometer. 2022 [cited 2022 Jan 10]. Available from: https://www.worldometers.info/coronavirus/#countries
    • Guo L, Ren L, Yang S, Xiao M, Chang D, Yang F, et al. Profiling early humoral response to diagnose novel coronavirus disease (COVID-19). Clin. Infect. Dis. 2020; 71: 778–785. doi: 10.1093/cid/ciaa310
    • Jia X, Zhang P, Tian Y, Wang J, Zeng H, Wang J, et al. Clinical significance of IgM and IgG test for diagnosis of highly suspected COVID-19 infection. Front Med. 2021; 8: 569266.  doi: 10.3389/fmed.2021.569266.
    • Kramarov S, Кoloskova O, Bilous T, Іvanova L, Kaminska T, Nezgoda I, et al. Peculiarities of the course of coronavirus disease COVID-19 in children of various ages in certain regions of Ukraine. Medical Science. 2021; 25(110): 985–998.
    • Lai JW, Cheong KH. Superposition of COVID‐19 waves, anticipating a sustained wave, and lessons for the future. Bioessays. 2020; 42(12): 2000178. doi: 10.1002/bies.202000178.
    • Lynch KL, Whitman JD, Lacanienta NP, Beckerdite EW, Kastner SA, Shy BR, et al. Magnitude and kinetics of anti-SARS-CoV-2 antibody responses and their rela-tionship to disease severity. Clin. Infect. Dis. 2020; 72(2):301–308. doi: 10.1093/cid/ciaa979.
    • Marchenko AV, Ananieva MM, Faustova MO, Loban GA, Lytovchenko IY, Nikolishyn IA, et al. Epidemiological data on the detection of immunoglobulins of class IgM, IgG to SARS-CoV-2 among population of Poltava region. Wiad Lek. 2021; 74(5): 1134–1136. doi: 10.36740/WLek202105116
    • Nicol T, Lefeuvre C, Serri O, Pivert A, Joubaud F, Dubee V, et. al. Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: Two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immunoassay (NG Biotech). Journal of clinical virology. 2020; 129: 104511. doi: https://doi.org/10.1016/j.jcv.2020.104511
    • Vandenberg O, Martiny D, Rochas O, Belkum A, Kozlakidis Z. Considerations for diagnostic COVID-19 tests. Nat Rev Microbiol. 2020; 14: 1–13. doi: 10.1038/s41579-020-00461-z
    Publication of the article «World of Medicine and Biology» №1(79), 2022 year, 011-015 pages, index UDK 161.9:612.017
    DOI 10.26724/2079-8334-2022-1-79-11-15